Movicol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 acts as an osmotic agent that retains water within the intestinal lumen. By drawing water into the bowel, it softens the stool, expands its volume, and stimulates peristalsis, which together facilitate easier and more frequent evacuation.

The dose of Movicol is individualized by the prescribing healthcare professional based on the patient’s age, severity of constipation, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for Movicol in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals. Consultation with a physician is essential.

To order Movicol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Movicol provides a gentler, water‑based mechanism that softens stool without causing cramping. It is often preferred for chronic constipation because it has a lower risk of dependence and a more favorable tolerability profile.

Store Movicol at room temperature, preferably below 25 °C. Keep the solution in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

Movicol is taken orally as a liquid solution. The prescribed amount is usually mixed with a measured volume of water, shaken gently, and consumed immediately. Patients should drink the full mixture and may follow it with additional water if advised.

Serious risks include electrolyte imbalance, severe dehydration, and rare allergic reactions. Patients should seek medical attention if they experience symptoms such as rapid heartbeat, muscle weakness, severe abdominal pain, swelling, or difficulty breathing.

Movicol should be avoided in individuals with known mechanical bowel obstruction, severe renal impairment, or hypersensitivity to any of its components. It is also contraindicated in patients who are on certain electrolyte‑altering medications without appropriate monitoring.